Previous 10 | Next 10 |
2023-07-17 17:09:58 ET PTC Therapeutics ( NASDAQ: PTCT ) said on Monday that it had appointed Pierre Gravier as chief financial officer. Gravier previously served as a managing director in the healthcare group of Perella Weinberg Partner. Press Release For f...
PTC Therapeutics Appoints Experienced Healthcare Finance Strategist Pierre Gravier as Chief Financial Officer PR Newswire SOUTH PLAINFIELD, N.J. , July 17, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointment of Pierre Grav...
PTC Therapeutics Announces Virtual Presentation on Phenylketonuria (PKU) and Sepiapterin PR Newswire SOUTH PLAINFIELD, N.J. , July 11, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), announced today that the company will provide a virtual presen...
PTC Therapeutics Announces Results from MIT-E Clinical Trial of Vatiquinone for the Treatment of Mitochondrial Disease Associated Seizures PR Newswire SOUTH PLAINFIELD, N.J. , June 29, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today th...
PTC Therapeutics Shares Positive Interim Data from PIVOT-HD Clinical Trial in Huntington's Disease Patients PR Newswire - D ose-dependent lowering of blood Huntingtin (HTT) protein levels at 12 weeks - - Favorable tolerability profile with no treatment-related se...
2023-05-25 12:40:30 ET Summary I was bearish on PTC in my June 2022 note. Despite the stock having gained marginally since, I'm still expecting a downward correction in valuation. PTC Therapeutics is a rare disease specialist that earned $220m of revenues in Q123, primarily from i...
2023-05-24 14:26:51 ET Shares of Reata Pharmaceuticals ( NASDAQ: RETA ) and PTC Therapeutics ( PTCT ) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate for the neuromuscular disorder Friedreich's ataxia (FA). Whil...
2023-05-24 12:53:19 ET Gainers: Minority Equality Opportunities Acquisition ( MEOA ) +176% . Enveric Biosciences ( ENVB ) +82% . QuantaSing Group ( QSG ) +61% . EpicQuest Education Group ( EEIQ ) +51% . GigaCloud Technology ( GCT ) ...
2023-05-24 10:07:34 ET Gainers: Enveric Biosciences ( ENVB ) +100% . Zura Bio ( ZURA ) +37% . Kamada ( KMDA ) +19% . Organogenesis ( ORGO ) +16% . OptimizeRx ( OPRX ) +14% . Losers: PTC Therapeutics ( PTCT ) -24% ....
2023-05-24 05:11:28 ET PTC Therapeutics ( NASDAQ: PTCT ) has decided to discontinue its preclinical and early research programs in its gene therapy platform and to reduce its workforce by ~8%. In addition, the company informed its CFO Emily Hill that her employment will be ...
News, Short Squeeze, Breakout and More Instantly...
PTC Therapeutics Inc. Company Name:
PTCT Stock Symbol:
NASDAQ Market:
PTC Therapeutics Inc. Website:
PTC Therapeutics Announces Sepiapterin NDA Submission to FDA PR Newswire WARREN, N.J. , July 30, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the submission of the sepiapterin NDA to the U.S. FDA. The NDA submission is for the t...
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results PR Newswire WARREN, N.J. , July 25, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to r...
2024-07-12 10:00:03 ET Jeffrey Hung from Morgan Stanley issued a price target of $32.00 for PTCT on 2024-07-12 08:15:00. The adjusted price target was set to $32.00. At the time of the announcement, PTCT was trading at $33.2. The overall price target consensus is at $43....